# Clopidogrel and Aspirin for the Treatment of Polycythemia Vera

> **NCT00940784** · PHASE2 · WITHDRAWN · sponsor: **Ronald Hoffman**

## Conditions studied

- Polycythemia Vera

## Interventions

- **DRUG:** Clopidogrel (Plavix)
- **DRUG:** Placebo
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT00940784
- **Lead sponsor:** Ronald Hoffman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-06
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Could not get drug
- **Last updated:** 2014-11-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940784, "Clopidogrel and Aspirin for the Treatment of Polycythemia Vera". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00940784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*